8 weeks of sofosbuvir/ledipasvir is effective in DAA-naive non-cirrhotic HCV genotype 4 infected patients (HEPNED-001 study)
Boerekamps, Anne, Vanwolleghem, Thomas, van der Valk, Marc, van den Berk, Guido E., van Kasteren, Marjo, Posthouwer, Dirk, Dofferhoff, Anthonius S.M., van Hoek, Bart, Ramsoekh, Dewkoemar, Koopsen, JelLanguage:
english
Journal:
Journal of Hepatology
DOI:
10.1016/j.jhep.2018.10.032
Date:
December, 2018
File:
PDF, 296 KB
english, 2018